Genovis Reports Significant Q2 2025 EBITDA Growth
Genovis achieves significant EBITDA growth in Q2 2025, reflecting strong financial performance in the pharmaceutical sector.
Genovis achieves significant EBITDA growth in Q2 2025, reflecting strong financial performance in the pharmaceutical sector.
Genovis achieves significant EBITDA growth in Q2 2025, reflecting strong financial performance in the pharmaceutical sector.